Omnicell EBITDA Margin 2010-2024 | OMCL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Omnicell (OMCL) over the last 10 years. The current EBITDA margin for Omnicell as of March 31, 2024 is .
| Omnicell EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-03-31 |
$1.10B |
$0.07B |
5.89% |
| 2023-12-31 |
$1.15B |
$0.07B |
5.66% |
| 2023-09-30 |
$1.19B |
$0.05B |
4.21% |
| 2023-06-30 |
$1.24B |
$0.07B |
5.34% |
| 2023-03-31 |
$1.27B |
$0.07B |
5.68% |
| 2022-12-31 |
$1.30B |
$0.10B |
7.79% |
| 2022-09-30 |
$1.31B |
$0.15B |
11.76% |
| 2022-06-30 |
$1.26B |
$0.17B |
13.21% |
| 2022-03-31 |
$1.20B |
$0.18B |
15.18% |
| 2021-12-31 |
$1.13B |
$0.20B |
17.40% |
| 2021-09-30 |
$1.07B |
$0.20B |
18.97% |
| 2021-06-30 |
$0.99B |
$0.18B |
17.71% |
| 2021-03-31 |
$0.92B |
$0.13B |
14.21% |
| 2020-12-31 |
$0.89B |
$0.11B |
12.65% |
| 2020-09-30 |
$0.89B |
$0.11B |
11.88% |
| 2020-06-30 |
$0.91B |
$0.12B |
13.23% |
| 2020-03-31 |
$0.92B |
$0.15B |
15.69% |
| 2019-12-31 |
$0.90B |
$0.15B |
16.16% |
| 2019-09-30 |
$0.86B |
$0.14B |
16.14% |
| 2019-06-30 |
$0.84B |
$0.13B |
15.31% |
| 2019-03-31 |
$0.81B |
$0.11B |
13.99% |
| 2018-12-31 |
$0.79B |
$0.10B |
12.44% |
| 2018-09-30 |
$0.77B |
$0.10B |
12.31% |
| 2018-06-30 |
$0.76B |
$0.09B |
11.79% |
| 2018-03-31 |
$0.75B |
$0.08B |
10.98% |
| 2017-12-31 |
$0.71B |
$0.06B |
8.98% |
| 2017-09-30 |
$0.69B |
$0.06B |
9.25% |
| 2017-06-30 |
$0.68B |
$0.06B |
8.65% |
| 2017-03-31 |
$0.67B |
$0.06B |
9.05% |
| 2016-12-31 |
$0.70B |
$0.08B |
11.78% |
| 2016-09-30 |
$0.65B |
$0.07B |
10.91% |
| 2016-06-30 |
$0.60B |
$0.07B |
11.85% |
| 2016-03-31 |
$0.54B |
$0.08B |
13.91% |
| 2015-12-31 |
$0.48B |
$0.07B |
15.29% |
| 2015-09-30 |
$0.48B |
$0.07B |
15.55% |
| 2015-06-30 |
$0.46B |
$0.07B |
15.73% |
| 2015-03-31 |
$0.46B |
$0.07B |
15.57% |
| 2014-12-31 |
$0.44B |
$0.07B |
15.84% |
| 2014-09-30 |
$0.43B |
$0.07B |
15.73% |
| 2014-06-30 |
$0.41B |
$0.06B |
15.48% |
| 2014-03-31 |
$0.40B |
$0.06B |
15.15% |
| 2013-12-31 |
$0.38B |
$0.05B |
14.17% |
| 2013-09-30 |
$0.37B |
$0.05B |
14.25% |
| 2013-06-30 |
$0.36B |
$0.05B |
14.65% |
| 2013-03-31 |
$0.34B |
$0.04B |
12.80% |
| 2012-12-31 |
$0.31B |
$0.04B |
12.78% |
| 2012-09-30 |
$0.29B |
$0.03B |
11.89% |
| 2012-06-30 |
$0.27B |
$0.03B |
9.77% |
| 2012-03-31 |
$0.25B |
$0.03B |
10.71% |
| 2011-12-31 |
$0.25B |
$0.02B |
9.80% |
| 2011-09-30 |
$0.24B |
$0.02B |
8.37% |
| 2011-06-30 |
$0.23B |
$0.02B |
7.79% |
| 2011-03-31 |
$0.23B |
$0.02B |
8.00% |
| 2010-12-31 |
$0.22B |
$0.02B |
8.56% |
| 2010-09-30 |
$0.22B |
$0.02B |
8.64% |
| 2010-06-30 |
$0.22B |
$0.02B |
7.80% |
| 2010-03-31 |
$0.22B |
$0.02B |
6.94% |
| 2009-12-31 |
$0.21B |
$0.01B |
5.14% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$1.229B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
